Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran

Translated title of the contribution: Preliminary results with the use of the GnRH antagonist Cetrorefix in in-vitro fertilization treatment

J. Urbancsek, Z. Vass, P. Fancsovits, E. Hauzman, N. Devenyi, G. Z. Tothne, E. Pohola

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The authors report preliminary results of 10 patients participating in a multicentric international study, into the efficacy and safety of the GnRH antagonist Cetrorelix in women undergoing controlled ovarian stimulation for IVF/ICSI treatment. Results suggest that co-treatment with GnRH antagonist Cetrorelix decreases the duration of stimulation, the number of gonadotropin ampoules used and the prevalence of hyperstimulation syndrome without compromising the number and quality of oocytes or preembryos and the fertilization or pregnancy rate, compared to stimulation with 'conventional' GnRH agonist + gonadotropin regimen. These encouraging results may be due to the improved endocrine milieu (prevention of premature LH surge and gradual incrase of serum estradiol concentration) as seen during 'conventional' GnRH agonist + gonadotropin cycles. The authors are the first in Hungary to report on clinical pregnancies with the use of GnRH antagonist Cetrorelix.

Original languageHungarian
Pages (from-to)357-363
Number of pages7
JournalMagyar Noorvosok Lapja
Volume63
Issue number5
Publication statusPublished - 2000

Fingerprint

Fertilization in Vitro
Gonadotropin-Releasing Hormone
Gonadotropins
Therapeutics
Intracytoplasmic Sperm Injections
Hungary
Ovulation Induction
Pregnancy Rate
Fertilization
Oocytes
Estradiol
Safety
Pregnancy
Serum
cetrorelix

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Urbancsek, J., Vass, Z., Fancsovits, P., Hauzman, E., Devenyi, N., Tothne, G. Z., & Pohola, E. (2000). Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran. Magyar Noorvosok Lapja, 63(5), 357-363.

Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran. / Urbancsek, J.; Vass, Z.; Fancsovits, P.; Hauzman, E.; Devenyi, N.; Tothne, G. Z.; Pohola, E.

In: Magyar Noorvosok Lapja, Vol. 63, No. 5, 2000, p. 357-363.

Research output: Contribution to journalArticle

Urbancsek, J, Vass, Z, Fancsovits, P, Hauzman, E, Devenyi, N, Tothne, GZ & Pohola, E 2000, 'Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran', Magyar Noorvosok Lapja, vol. 63, no. 5, pp. 357-363.
Urbancsek, J. ; Vass, Z. ; Fancsovits, P. ; Hauzman, E. ; Devenyi, N. ; Tothne, G. Z. ; Pohola, E. / Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran. In: Magyar Noorvosok Lapja. 2000 ; Vol. 63, No. 5. pp. 357-363.
@article{1099fbf83f7f41edb63855b4a4f4df8c,
title = "Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran",
abstract = "The authors report preliminary results of 10 patients participating in a multicentric international study, into the efficacy and safety of the GnRH antagonist Cetrorelix in women undergoing controlled ovarian stimulation for IVF/ICSI treatment. Results suggest that co-treatment with GnRH antagonist Cetrorelix decreases the duration of stimulation, the number of gonadotropin ampoules used and the prevalence of hyperstimulation syndrome without compromising the number and quality of oocytes or preembryos and the fertilization or pregnancy rate, compared to stimulation with 'conventional' GnRH agonist + gonadotropin regimen. These encouraging results may be due to the improved endocrine milieu (prevention of premature LH surge and gradual incrase of serum estradiol concentration) as seen during 'conventional' GnRH agonist + gonadotropin cycles. The authors are the first in Hungary to report on clinical pregnancies with the use of GnRH antagonist Cetrorelix.",
keywords = "Cetrorelix, Controlled ovarian stimulation, Fertilization in vitro, GnRH antagonists",
author = "J. Urbancsek and Z. Vass and P. Fancsovits and E. Hauzman and N. Devenyi and Tothne, {G. Z.} and E. Pohola",
year = "2000",
language = "Hungarian",
volume = "63",
pages = "357--363",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "5",

}

TY - JOUR

T1 - Kezdeti tapasztalataink a GnRH-antagonista cetrorelix in vitro fertilizacios kezelesben valo alkalmazasa soran

AU - Urbancsek, J.

AU - Vass, Z.

AU - Fancsovits, P.

AU - Hauzman, E.

AU - Devenyi, N.

AU - Tothne, G. Z.

AU - Pohola, E.

PY - 2000

Y1 - 2000

N2 - The authors report preliminary results of 10 patients participating in a multicentric international study, into the efficacy and safety of the GnRH antagonist Cetrorelix in women undergoing controlled ovarian stimulation for IVF/ICSI treatment. Results suggest that co-treatment with GnRH antagonist Cetrorelix decreases the duration of stimulation, the number of gonadotropin ampoules used and the prevalence of hyperstimulation syndrome without compromising the number and quality of oocytes or preembryos and the fertilization or pregnancy rate, compared to stimulation with 'conventional' GnRH agonist + gonadotropin regimen. These encouraging results may be due to the improved endocrine milieu (prevention of premature LH surge and gradual incrase of serum estradiol concentration) as seen during 'conventional' GnRH agonist + gonadotropin cycles. The authors are the first in Hungary to report on clinical pregnancies with the use of GnRH antagonist Cetrorelix.

AB - The authors report preliminary results of 10 patients participating in a multicentric international study, into the efficacy and safety of the GnRH antagonist Cetrorelix in women undergoing controlled ovarian stimulation for IVF/ICSI treatment. Results suggest that co-treatment with GnRH antagonist Cetrorelix decreases the duration of stimulation, the number of gonadotropin ampoules used and the prevalence of hyperstimulation syndrome without compromising the number and quality of oocytes or preembryos and the fertilization or pregnancy rate, compared to stimulation with 'conventional' GnRH agonist + gonadotropin regimen. These encouraging results may be due to the improved endocrine milieu (prevention of premature LH surge and gradual incrase of serum estradiol concentration) as seen during 'conventional' GnRH agonist + gonadotropin cycles. The authors are the first in Hungary to report on clinical pregnancies with the use of GnRH antagonist Cetrorelix.

KW - Cetrorelix

KW - Controlled ovarian stimulation

KW - Fertilization in vitro

KW - GnRH antagonists

UR - http://www.scopus.com/inward/record.url?scp=0033782202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033782202&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 357

EP - 363

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 5

ER -